154 related articles for article (PubMed ID: 6795820)
1. [Effect of prodectin and lipoic acid on the lipid metabolism indicators in chronic ischemic heart disease].
Grigor'ian VA; Klantsa NA; Prishliak VD; Klantsa PN
Vrach Delo; 1981 Oct; (10):13-5. PubMed ID: 6795820
[No Abstract] [Full Text] [Related]
2. [Effect of Production on the serum lipid and lipoprotein level in ischemic heart disease].
Orbetsov M; Orbetsova V; Todorova M; Mikhaĭlova M; Atanasova M
Vutr Boles; 1977; 16(6):16-22. PubMed ID: 203118
[TBL] [Abstract][Full Text] [Related]
3. [Current trends in the therapy of arteriosclerotic disease].
Toscano S
G Clin Med; 1974 Jan; 55(1):27-39. PubMed ID: 4369524
[No Abstract] [Full Text] [Related]
4. [Activity of the kallikrein-kinin system in patients with ischemic heart disease treated with parmidine].
Vygovskiĭ VP; Zaremba EF; Podil'chak EM; Dutka RIa; Gorgota OV
Vrach Delo; 1985 Sep; (9):6-8. PubMed ID: 2416131
[No Abstract] [Full Text] [Related]
5. [Effect of complamin and prodectin on microcirculation and lipid metabolism in psoriasis patients].
Rakhmatov AB; Bilash NV
Vestn Dermatol Venerol; 1983 Apr; (4):15-8. PubMed ID: 6868813
[No Abstract] [Full Text] [Related]
6. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
Citarrella P; Abbadessa V; Pecorella M; Cajozzo A
Boll Soc Ital Cardiol; 1977; 22(7):1036-41. PubMed ID: 618239
[No Abstract] [Full Text] [Related]
7. Alpha lipoic acid possess dual antioxidant and lipid lowering properties in atherosclerotic-induced New Zealand White rabbit.
Zulkhairi A; Zaiton Z; Jamaluddin M; Sharida F; Mohd TH; Hasnah B; Nazmi HM; Khairul O; Zanariyah A
Biomed Pharmacother; 2008 Dec; 62(10):716-22. PubMed ID: 18538528
[TBL] [Abstract][Full Text] [Related]
8. [Blood plasma prostaglandins and their role in disorders of lipid metabolism in ischemic heart disease caused by coronary arteriosclerosis].
Bochkareva EV; Zykova VP; Lobova NM; Polesskiĭ VA; Gadzhanova SI
Ter Arkh; 1980; 52(5):18-22. PubMed ID: 7404361
[No Abstract] [Full Text] [Related]
9. [Atheroid and anginin in diabetic retinopathy].
Margolis MG; Zefirova GS; Shul'pina NB
Vestn Oftalmol; 1973; 1():38-41. PubMed ID: 4130225
[No Abstract] [Full Text] [Related]
10. [Pyridinolcarbamate treatment of ischemic heart disease].
Kuz'ko NV
Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
[No Abstract] [Full Text] [Related]
11. [Study of hypolipemic effect of atheroid in ischemic heart disease associated with various types of hyperlipoproteinemia].
Zakharov VN
Sov Med; 1978 Jan; (1):147-8. PubMed ID: 76342
[No Abstract] [Full Text] [Related]
12. Influence of simvastatin on LDL-subtypes in patients with heterozygous familial hypercholesterolemia and in patients with diabetes mellitus and mixed hyperlipoproteinemia.
Geiss HC; Schwandt P; Parhofer KG
Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):182-7. PubMed ID: 12058342
[TBL] [Abstract][Full Text] [Related]
13. [Characteristics of lipid metabolism in patients with ischemic heart disease with ventricular extrasystole and without rhythm disorders].
Murashko VV; Alekseeva NV; Strutynskiĭ AV; Moshkova NK
Lab Delo; 1986; (6):335-8. PubMed ID: 2427776
[No Abstract] [Full Text] [Related]
14. Cholesterol of alpha and beta lipoproteins in ischemic heart disease.
Alvarado M; Méndez D; Rivera-Hidalgo PR
Arch Invest Med (Mex); 1981; 12(4):589-98. PubMed ID: 7332395
[No Abstract] [Full Text] [Related]
15. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
Orbetzova V; Jurukova Z; Orbetzova M
Artery; 1980; 8(6):560-9. PubMed ID: 7259535
[TBL] [Abstract][Full Text] [Related]
16. [Lipid metabolism and oxidation-reduction properties of blood in patients with arteriosclerotic myocardiosclerosis during treatment with lipoic acid].
Mikunis RI; Serkova VK; Shirkova TA
Vrach Delo; 1976 Mar; (3):39-42. PubMed ID: 775779
[No Abstract] [Full Text] [Related]
17. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
Herrmann W; Reuter W
Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
[No Abstract] [Full Text] [Related]
18. Results obtained with prodectin in arteriosclerotic arterial obliteration of the lower extremities.
Hunyi L
Ther Hung; 1976; 24(2):67-71. PubMed ID: 982342
[No Abstract] [Full Text] [Related]
19. [Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases].
Ferlito S; La Spina E; Cultrera E; Puleo F; Carrà G
Arch Sci Med (Torino); 1982; 139(2):175-81. PubMed ID: 7138283
[TBL] [Abstract][Full Text] [Related]
20. [Changes of the blood kallikrein-kinin system in patients with diffuse toxic goiter under the influence of thyrostatic therapy and prodectin].
Matiashina GI
Vrach Delo; 1989 Apr; (4):31-3. PubMed ID: 2474220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
